UGDH Antikörper

Produktnummer ABIN2856009

Produktdetails anti-UGDH Antikörper

Target: UGDH (UDP-Glucose 6-Dehydrogenase (UGDH))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser UGDH Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)

Kreuzreaktivität: Human, Maus, Ratte

Produktmerkmale: Rabbit Polyclonal antibody to UGDH (UDP-glucose 6-dehydrogenase)
UGDH antibody

Aufreinigung: Purified by antigen-affinity chromatography.

Immunogen: Recombinant protein encompassing a sequence within the center region of human UGDH. The exact sequence is proprietary.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB: 1:1000-1:10000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Kommentare:

Positive Control: mouse liver , Rat liver , UGDH-transfected 293T

Validation: Orthogonal, Overexpression

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.36 mg/mL

Buffer: 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Details zu UGDH

Target: UGDH (UDP-Glucose 6-Dehydrogenase (UGDH))

Andere Bezeichnung: UDP-glucose 6-dehydrogenase (UGDH Produkte)

Synonyme: 8310 antikoerper, BG01214 antikoerper, CG10072 antikoerper, Dmel\\CG10072 antikoerper, Sgl antikoerper, UDP-GlcDH antikoerper, UDPGDH antikoerper, XIII antikoerper, kiwi antikoerper, l(3)05007 antikoerper, l(3)08310 antikoerper, l(3)10503 antikoerper, l(3)65CEd antikoerper, l(3)SG9 antikoerper, ska antikoerper, sl antikoerper, ik:tdsubc_2a8 antikoerper, tdsubc_2a8 antikoerper, xx:tdsubc_2a8 antikoerper, gdh antikoerper, ugd antikoerper, ugdh antikoerper, ugdhb antikoerper, xugdh antikoerper, udpgdh antikoerper, udpg antikoerper, ugdha antikoerper, BA5434 antikoerper, SCBAC19G2.07 antikoerper, AGR_L_1413 antikoerper, udg antikoerper, GDH antikoerper, UGD antikoerper, Udpgdh antikoerper, sugarless antikoerper, UDP-glucose 6-dehydrogenase antikoerper, UDP-glucose 6-dehydrogenase L homeolog antikoerper, UDP-glucose 6-dehydrogenase S homeolog antikoerper, UDP-glucose dehydrogenase WcvB antikoerper, UDP-glucose dehydrogenase antikoerper, sgl antikoerper, ugdh antikoerper, ugdh.L antikoerper, UGDH antikoerper, ugdh.S antikoerper, hasB antikoerper, ugdH antikoerper, ugd antikoerper, SCO3052 antikoerper, wcvB antikoerper, CNL06460 antikoerper, Ugdh antikoerper

Hintergrund: The protein encoded by this gene converts UDP-glucose to UDP-glucuronate and thereby participates in the biosynthesis of glycosaminoglycans such as hyaluronan, chondroitin sulfate, and heparan sulfate. These glycosylated compounds are common components of the extracellular matrix and likely play roles in signal transduction, cell migration, and cancer growth and metastasis. The expression of this gene is up-regulated by transforming growth factor beta and down-regulated by hypoxia.

Molekulargewicht: 55 kDa

Gen-ID: 7358

UniProt: O60701

Pathways: Glycosaminoglycan Metabolic Process